Nektar Therapeutics (Nasdaq: NKTR) today announced its financial results for the third quarter ended September 30, 2026, and provided a business update.
India has reaffirmed its commitment to climate multilateralism and the principles of equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results